|
(PQD1) Treatment-emergent resistance to NEDD8-activating enzyme inhibition
|
4R01CA180150-04
|
$558,328
|
PETROSKI, MATTHEW
|
SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INST
|
|
(PQD5) A novel genetic strategy to predict efficacy of anti-CD20 antibodies
|
5R01CA185372-03
|
$321,937
|
RICHARDS, KRISTY
|
CORNELL UNIVERSITY
|
|
A cohort study among workers exposed to benzene in China
|
ZIA CP010120-02060
|
$44,764
|
Rothman, Nathaniel
|
DCEG (NCI)
|
|
A Modifier of Plasmacytoma Susceptibility Maps to Mouse Chr 1
|
ZIA BC 011064
|
$35,597
|
Mock, Beverly
|
CCR (NCI)
|
|
A MULTILEVEL APPROACH TO ENERGY BALANCE AND CANCER ACROSS THE LIFECOURSE
|
3U54CA155496-05S1
|
$401,250
|
COLDITZ, GRAHAM
|
WASHINGTON UNIVERSITY
|
|
A new small molecule targeting agent and therapeutic for non-Hodgkin's lymphoma
|
3R44CA159843-03S1
|
$94,422
|
BALHORN, RODNEY
|
SHAL TECHNOLOGIES, INC.
|
|
A New Treatment Paradigm for ALK-Driven Cancers Exploiting Oncogene Overdose
|
5R01CA190696-03
|
$299,009
|
SCHATZ, JONATHAN
|
UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
|
|
A novel NKG2D-specific BiTE cancer immunotherapy
|
4R01CA164178-04
|
$336,150
|
SENTMAN, CHARLES
|
DARTMOUTH COLLEGE
|
|
A Novel Positron Emission Tomography Strategy for Early Detection and Treatment Monitoring of Graft-versus-host Disease
|
1R01CA201719-01
|
$361,499
|
GAMBHIR, SANJIV
|
STANFORD UNIVERSITY
|
|
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL
|
1R01CA196266-01A1
|
$504,843
|
PENICHET, MANUEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A Novel Strategy Targeting TfR1 for the Prevention/Treatment of AIDS-related NHL
|
3R01CA196266-01A1S1
|
$196,920
|
PENICHET, MANUEL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
A Pathway of Tumor Suppression
|
4R01CA047296-28
|
$249,580
|
LOZANO, GUILLERMINA
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
A Phase I/II Clinical Trial to Investigate Fucosylated Tregs in Prevention of GVHD
|
5R44CA192601-02
|
$467,137
|
FLAIM, JOANN
|
TARGAZYME, INC.
|
|
A Phase IIa Study of rHuIL-12 as an Immunotherapy and Radiomitigator for CTCL Patients Receiving Radiotherapy
|
5R44CA192576-02
|
$417,175
|
BASILE, LENA
|
NEUMEDICINES, INC.
|
|
A Role for KSHV in the Pathogenesis of Malignancies
|
ZIA SC 010356
|
$268,745
|
Tosato, Giovanna
|
CCR (NCI)
|
|
A Stepped-Care Telehealth Approach to Treat Distress in Rural Cancer Survivors
|
1R21CA198237-01A1
|
$202,275
|
DANHAUER, SUZANNE
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
|
Abramson Cancer Center Support Grant
|
2P30CA016520-40
|
$7,975,543
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S1
|
$31,250
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S2
|
$499,967
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-40S3
|
$200,000
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Activation of Proto-Oncogenes by Chromosomal Translocation
|
ZIA SC 010378
|
$322,076
|
Aplan, Peter
|
CCR (NCI)
|
|
Addressing Herpesvirus-associated Cancers through the UNC-Malawi Cancer Consortiu
|
5U54CA190152-03
|
$699,897
|
GOPAL, SATISH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Adult Leukemia Research Center
|
4P01CA018029-41
|
$4,225,448
|
APPELBAUM, FREDERICK
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
AIDS Malignancy Consortium (AMC)
|
5UM1CA121947-10
|
$21,619,997
|
MITSUYASU, RONALD
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S1
|
$1,595,651
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S2
|
$550,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
3U10CA180821-03S3
|
$750,000
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Alliance for Clinical Trials in Oncology Operations Center
|
5U10CA180821-03
|
$9,068,022
|
BERTAGNOLLI, MONICA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
Allogeneic T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIA BC 011415
|
$41,944
|
Kochenderfer, James
|
CCR (NCI)
|
|
Allotransplant for DOCK8 deficiency
|
ZIA BC 011374
|
$441,849
|
Hickstein, Dennis
|
CCR (NCI)
|
|
Alpha Radioimmunotherapy for Lymphoma Treatment
|
4R01CA172582-04
|
$634,846
|
SANDMAIER, BRENDA
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Alternative End-Joining in DNA Repair and Chromosomal Translocations
|
5F30CA189740-03
|
$31,559
|
KUMAR, VIPUL
|
HARVARD MEDICAL SCHOOL
|
|
An Early-Phase Clinical Trial Evaluating ABC294640 in Patients with Refractory/Re
|
5R42CA183708-05
|
$133,116
|
PARSONS, CHRISTOPHER
|
APOGEE BIOTECHNOLOGY CORPORATION
|
|
Analysis and Therapeutic Targeting Non-proteolytic Protein Ubiquitination in Diffuse Large B Cell Lymphoma
|
1K22CA197014-01
|
$194,616
|
YANG, YIBIN
|
RESEARCH INST OF FOX CHASE CAN CTR
|
|
Anatomic Pathology Residency Program
|
ZIE BC 011384
|
$1,014,935
|
Barr, Frederic
|
CCR (NCI)
|
|
Animal Model and Genotyping Core Support Facility
|
ZIC BC 011047
|
$1,011,302
|
DuBois, Wendy
|
CCR (NCI)
|
|
Annual International Primary CNS Lymphoma Collaborative Group Meeting
|
2R13CA124293-09
|
$2,500
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Anticancer drug-induced BH3-only protein.Bak interactions
|
4R01CA166741-05
|
$329,925
|
KAUFMANN, SCOTT
|
MAYO CLINIC ROCHESTER
|
|
Antigen-specific T cell Redirectors, ATR, for immunotherapy
|
5R21CA185819-02
|
$211,410
|
SCHNECK, JONATHAN
|
JOHNS HOPKINS UNIVERSITY
|
|
Arrayed drug microinjection for guiding precision medicine in relapsed lymphoma
|
2R44CA144104-04
|
$1,053,521
|
KLINGHOFFER, RICHARD
|
PRESAGE BIOSCIENCES, INC.
|
|
ATBC Study
|
ZIA CP010195-03031
|
$1,193,520
|
Albanes, Demetrius
|
DCEG (NCI)
|
|
Autologous T cells Transduced with an Anti-CD19 Chimeric Antigen Receptor
|
ZIA BC 011413
|
$167,778
|
Kochenderfer, James
|
CCR (NCI)
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV-AIDS Research
|
ZIG BC 010856
|
$14,732,997
|
Custer, Mary
|
CCR (NCI)
|
|
BCR Signaling in ABC DLBCL
|
ZIA BC 011354
|
$107,270
|
Wilson, Wyndham
|
CCR (NCI)
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$791,464
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
Biochemical Basis of T Cell Activation
|
ZIA BC 010304
|
$1,437,752
|
Samelson, Lawrence
|
CCR (NCI)
|
|
Biologic Determinants of the Natural History of AIDS-Defining Cancers in Uganda
|
5U54CA190146-03
|
$693,281
|
CASPER, COREY
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
Biology and Transplantation of the Hematopoietic Stem Cell
|
5P01CA065493-22
|
$1,914,901
|
WAGNER, JOHN
|
UNIVERSITY OF MINNESOTA
|
|
Biomarkers and Therapeutic Targets in Angiogenesis and Metastasis
|
ZIA BC 011334
|
$353,472
|
Kaplan, Rosandra
|
CCR (NCI)
|
|
Biomarkers of benzene exposure
|
ZIA CP010121-02035
|
$52,989
|
Rothman, Nathaniel
|
DCEG (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|